Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

12.05
Delayed Data
As of Jan 20
 0.00 / 0.00%
Today’s Change
11.88
Today|||52-Week Range
40.74
-9.06%
Year-to-Date

Today’s Trading

Previous close12.05
Today’s open12.10
Day’s range11.95 - 12.25
Volume1,026,625
Average volume (3 months)1,284,380
Market cap$890.2M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)-20.01%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+44.36%
P/E ratioNM
Price/Sales3.58
Price/Book0.82

Competitors

 Today’s
change
Today’s
% change
CLCDCoLucid Pharmaceutic...-0.05-0.11%
AIMTAimmune Therapeutics...-0.18-0.95%
INSMInsmed Inc+0.24+1.55%
CORTCorcept Therapeutics...-0.20-2.63%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateFebruary 28, 2017
EPS forecast (this quarter)$0.15
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
J. Kevin Buchi
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts


Search for Jobs